Form 4 for BSX Boston Scientific
Accepted 2025-06-03 00:00:00 ET · period of report 2025-06-02 · accession 0001225208-25-005681 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-06-03 | 2025-06-02 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $103.69 | -164.4K | 1.57M | -9% | -$17.05M |
| DM | 2025-06-03 | 2025-06-02 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $20.67 | +105.6K | 1.64M | +7% | +$2.18M |
| DM | 2025-06-03 | 2025-06-02 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | -105.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-02 | S | D | 89,921 | $103.39 | 1,476,882 | D | — | — | (F3) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $102.83 to $103.825 inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2025-06-02 | M | A | 56,212 | $17.26 | 1,591,918 | D | — | — | |
| 3 | Common | Common Stock | 2025-06-02 | M | A | 49,407 | $24.55 | 1,641,325 | D | — | — | |
| 4 | Common | Common Stock | 2025-06-02 | S | D | 74,522 | $104.05 | 1,566,803 | D | — | — | (F2) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $103.83 to $104.755, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-06-02 | M | D | 49,407 | $0.00 | 148,221 | D | $24.55 · — to 2027-02-28 | 49,407 Common Stock | (F5) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant. |
| 6 | Derivative | Stock Option (Right to Buy) | 2025-06-02 | M | D | 56,212 | $0.00 | 0 | D | $17.26 · — to 2026-02-22 | 56,212 Common Stock | (F4) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant. |